Chandra Bartholomeusz
- Oncology top 5%
- HER2/EGFR in Cancer Research 9
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 7
- Cancer Research top 5%
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 7
- FOXO transcription factor regulation 5
-
- Lung Cancer Treatments and Mutations 5
- Immunology and Allergy top 10%
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Cancer Research and Treatments 5
- Co-authors
- Naoto T. UenoGabriel N. HortobágyiDongwei ZhangAna M. González-AnguloHiroko MasudaHiroyoshi DoiharaFumiyuki YamasakiKevin N. Dalby
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Chandra Bartholomeusz
42 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 867
- Cancer Research 416
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 321
- Immunology and Allergy 52
Countries citing papers authored by Chandra Bartholomeusz
This map shows the geographic impact of Chandra Bartholomeusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Bartholomeusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Bartholomeusz more than expected).
Fields of papers citing papers by Chandra Bartholomeusz
This network shows the impact of papers produced by Chandra Bartholomeusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Bartholomeusz. The network helps show where Chandra Bartholomeusz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chandra Bartholomeusz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2020 | 20 | |
| 4 | 2020 | 28 | |
| 5 | 2019 | 20 | |
| 6 | 2017 | 29 | |
| 7 | 2016 | 78 | |
| 8 | 2015 | 59 | |
| 9 | 2015 | 50 | |
| 10 | 2014 | 26 | |
| 11 | 2014 | 43 | |
| 12 | 2014 | 9 | |
| 13 | 2013 | 8 | |
| 14 | 2012 | 22 | |
| 15 | 2011 | 23 | |
| 16 | 2011 | 12 | |
| 17 | 2011 | 20 | |
| 18 | 2008 | 60 | |
| 19 | 2008 | 69 | |
| 20 | E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. | 2000 | 82 |
About Chandra Bartholomeusz
Chandra Bartholomeusz is a scholar working on Oncology, Biotechnology and Immunology and Allergy, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer-related Molecular Pathways (9 papers), Melanoma and MAPK Pathways (7 papers), Cancer Cells and Metastasis (7 papers), FOXO transcription factor regulation (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Oncology (867 citations), Cancer Research (416 citations) and Molecular Biology (1.2k citations). Chandra Bartholomeusz has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Naoto T. Ueno, Gabriel N. Hortobágyi, Dongwei Zhang, Ana M. González-Angulo, Hiroko Masuda, Hiroyoshi Doihara, Fumiyuki Yamasaki, Kevin N. Dalby, Francisco J. Esteva and Kaoru Kurisu. Their work appears in journals such as Cancer Research, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.